Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Southeastern Medical Oncology Center - Goldsboro
mi
from
Goldsboro, NC
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Wayne Memorial Hospital
mi
from
Goldsboro, NC
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Benefis Healthcare- Sletten Cancer Institute
mi
from
Great Falls, MT
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Green Bay Oncology Limited at Saint Mary's Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Gibbs Cancer Center-Pelham
mi
from
Greer, SC
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Swedish Cancer Institute-Issaquah
mi
from
Issaquah, WA
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Kalispell Regional Medical Center
mi
from
Kalispell, MT
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Cancer Center of Kansas, PA - Kingman
mi
from
Kingman, KS
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Gundersen Lutheran Medical Center
mi
from
La Crosse, WI
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Marshfield Clinic - Ladysmith Center
mi
from
Ladysmith, WI
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Toledo Clinic Cancer Centers-Maumee
mi
from
Maumee, OH
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Idaho Urologic Institute - Meridian
mi
from
Meridian, ID
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Regional Hematology and Oncology PA
mi
from
Newark, DE
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Illinois CancerCare-Ottawa Clinic
mi
from
Ottawa, IL
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Menorah Medical Center
mi
from
Overland Park, KS
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Illinois CancerCare - Pekin
mi
from
Pekin, IL
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Kootenai Cancer Center
mi
from
Post Falls, ID
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Coborn Cancer Center at Saint Cloud Hospital
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Saint Cloud Hospital
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Saint Louis Cancer and Breast Institute-South City
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Springfield Clinic
mi
from
Springfield, IL
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memorial Medical Center
mi
from
Springfield, IL
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Green Bay Oncology - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Missouri Baptist Sullivan Hospital
mi
from
Sullivan, MO
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Cancer Care Specialists of Illinois-Swansea
mi
from
Swansea, IL
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KS
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Cancer Center of Kansas, PA - Winfield
mi
from
Winfield, KS
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Marshfield Clinic - Wisconsin Rapids Center
mi
from
Wisconsin Rapids, WI
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Providence Regional Cancer System-Yelm
mi
from
Yelm, WA
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Rush-Copley Healthcare Center
mi
from
Yorkville, IL
Click here to add this to my saved trials
Oncology Clinical Trial
International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric Cancer
Status: Enrolling
Updated: 3/1/2015
UCLA Medical Center
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Oncology Clinical Trial
International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric Cancer
Status: Enrolling
Updated: 3/1/2015
University of Massachusetts Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Anemia Clinical Trial
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Status: Enrolling, Phase II
Updated: 3/31/2016
GSK Investigational Site
mi
from
Amherst, NY
Click here to add this to my saved trials
Anemia Clinical Trial
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Status: Enrolling, Phase II
Updated: 3/31/2016
GSK Investigational Site
mi
from
Asheville, NC
Click here to add this to my saved trials
Anemia Clinical Trial
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Status: Enrolling, Phase II
Updated: 3/31/2016
GSK Investigational Site
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Anemia Clinical Trial
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Status: Enrolling, Phase II
Updated: 3/31/2016
GSK Investigational Site
mi
from
Middlebury, CT
Click here to add this to my saved trials
Anemia Clinical Trial
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Status: Enrolling, Phase II
Updated: 3/31/2016
GSK Investigational Site
mi
from
San Dimas, CA
Click here to add this to my saved trials
Anemia Clinical Trial
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Status: Enrolling, Phase II
Updated: 3/31/2016
GSK Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Metastatic Pancreatic Cancer Clinical Trial
BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Hospital of Rhode Island
mi
from
Pawtucket, RI
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
A Comparative Efficacy Study of DermaPure™ to Treat Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 11/4/2015
Carl T. Hayden Medical Research Foundation
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
A Phase I Study of Oral ABL001 in Patients With CML or Ph+ ALL
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Michigan Comprehensive Cancer Center SC
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Non-Erosive Reflux Disease Clinical Trial
Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study
Status: Enrolling
Updated: 12/31/1969
Department of Veterans Affairs Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Status: Enrolling, Phase IV
Updated: 12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KS
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Status: Enrolling, Phase IV
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Millennium Clinical Trials, L.L.C.
mi
from
Arlington, VA
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
White Oak Family Physicians, PA
mi
from
Asheboro, NC
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Northshore Allergy & Immunology, LLC
mi
from
Covington, LA
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Israel Machin M.D., PA
mi
from
Lake Clarke Shores, FL
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Advanced Behavioral Care, LLC
mi
from
Palm Bay, FL
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Centex Studies Inc
mi
from
Pharr, TX
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Scottsdale Cardiovascular Center
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling, Phase
Updated: 12/31/1969
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling, Phase
Updated: 12/31/1969
Rainbow Babies/ University Hospitals Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling, Phase
Updated: 12/31/1969
Primary Children's Medical Center - University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Long QT and Hearing Loss Registry
Status: Enrolling
Updated: 1/31/2018
Dell Children's Medical center
mi
from
Austin, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure
Status: Enrolling
Updated: 2/5/2018
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness
Status: Enrolling
Updated: 12/2/2015
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Premature Infants Requiring Non-invasive Respiratory Support Clinical Trial
Flow-synchronized Nasal IMV in Preterm Infants
Status: Enrolling
Updated: 12/31/1969
Holtz Childrens Hospital-Jackson Health System-University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Image-guided Cryoablation of Head, Neck and Spine Tumors
Status: Enrolling
Updated: 3/5/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Major Depression Clinical Trial
Comparing Engage to PST for Late Life Depression
Status: Enrolling
Updated: 12/31/1969
Weill Medical College of Cornell University
mi
from
White Plains, NY
Click here to add this to my saved trials
Neuromyelitis Optica Clinical Trial
Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses
Status: Enrolling, Phase I
Updated: 3/12/2014
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
PERIGON Pivotal Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Florida - Shands
mi
from
Gainesville, FL
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
PERIGON Pivotal Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Maimonides Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
PERIGON Pivotal Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Riverside Methodist Hospital (OhioHealth)
mi
from
Columbus, OH
Click here to add this to my saved trials
Trigeminal Neuralgia Clinical Trial
Botulinum Toxin for the Treatment of Trigeminal Neuralgia
Status: Enrolling, Phase II
Updated: 6/13/2016
Jefferson Headache Center at Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Barrett Metaplasia Clinical Trial
Tamoxifen to Treat Barrett's Metaplasia
Status: Enrolling, Phase
Updated: 1/6/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Thoracoabdominal Aortic Aneurysm Clinical Trial
Thoracoabdominal Aortic Aneurysms With Fenestrated and Branched Stent Grafts
Status: Enrolling
Updated: 3/29/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)
Status: Enrolling, Phase II
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Healthy Clinical Trial
Evaluation of an Oral Nutritional Supplement on Lean Body Mass in Healthy Older Subjects.
Status: Enrolling
Updated: 10/26/2015
Florida Hospital Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Portland Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Oncology Hematology Care
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Mayo Clinic
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
UPMC - Hillman Cancer Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Stanford Comprehensive Cancer Center
mi
from
Stanford, CA
Click here to add this to my saved trials
Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Status: Enrolling, Phase I
Updated: 12/31/1969
Site US00001
mi
from
Detroit, MI
Click here to add this to my saved trials
Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Status: Enrolling, Phase I
Updated: 12/31/1969
Site US00004
mi
from
Fairway, KS
Click here to add this to my saved trials
Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Status: Enrolling, Phase I
Updated: 12/31/1969
Site US10007
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Status: Enrolling, Phase I
Updated: 12/31/1969
Site US10009
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Acute Gastroenteritis Clinical Trial
A Multi-Site Clinical Evaluation of the ARIES Norovirus Assay
Status: Enrolling
Updated: 7/10/2015
Indiana Health
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Acute Gastroenteritis Clinical Trial
A Multi-Site Clinical Evaluation of the ARIES Norovirus Assay
Status: Enrolling
Updated: 7/10/2015
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Amarillo Center for Clinical Research
mi
from
Amarillo, TX
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Arthritis and Rheumatology of GA, P.C.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
RASF Clinical Research Center
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Weill Cornell Physicians at Brooklyn Heights
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Medical Associates of North Georgia
mi
from
Canton, GA
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Center for Arthritis and Rheumatic Diseases
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Coeur D'Alene Arthritis Clinic
mi
from
Coeur D'Alene, ID
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Arthritis Centers of Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
International Medical Research
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Med Investigations
mi
from
Fair Oaks, CA
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
CHI St. Vincent Medical Group Hot Springs
mi
from
Hot Springs, AR
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Accurate Clinical Management
mi
from
Houston, TX
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Rheumatology Associates Of North Alabama, P.C.
mi
from
Huntsville, AL
Click here to add this to my saved trials